AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2019 • PERRIGO Co PLC • Pharmaceutical preparations
The Employment Agreement made and entered into effective October 8, 2018 by and between Perrigo Management Company (the “Company”) and Murray Kessler (“Executive”), is hereby Amended by this Amendment No. 1, effective as of February 13, 2019 (this “Amendment”).
RE: Employment Separation and SeverancePerrigo Company Confidential Wavier and Release Agreement 1Waiver and Release Agreement • May 9th, 2019 • PERRIGO Co PLC • Pharmaceutical preparations
As a result of a decision by Perrigo to make a change in the Chief Financial Officer (“CFO”) role, your employment with Perrigo Company plc will end June 30, 2019 (“Executive’s Severance Date”); you will have no continued employment opportunity with Perrigo. This Waiver and Release Agreement 1 (“the Agreement” or “Agreement 1”) is entered into by and between Perrigo Company plc (“Perrigo” or “the Company”), and Ronald Winowiecki (“you” or “Employee” or “Executive”). As of March 25, 2019, you will step down from your CFO position and as compensation for doing so, you remain employed through June 30, 2019 (the “Severance Date”) to assist with the transition of duties; your compensation, including but not limited to your base salary at the rate of $643,150 per annum, will remain unchanged through the Executive’s Severance Date.
